iRhythm Technologies
Remote Patient Monitoring & Wearables
iRhythm is a leading digital health company that creates trusted solutions to detect, predict, and prevent cardiac disease.
About iRhythm Technologies
iRhythm Technologies is a digital health company that provides ambulatory cardiac monitoring services, including AI-assisted ECG analysis for arrhythmia detection.
Mission & Approach
Mission
“iRhythm is shaping the future of heart monitoring and empowering better health for all”
AI Approach
Deep learning for ECG signal analysis and arrhythmia detection
Products & Solutions
Zio AT
deviceAdvanced telemetry ECG monitor with real-time transmission capabilities
An advanced ambulatory cardiac telemetry monitor that provides continuous ECG monitoring with transmission capabilities. Does not require battery changes or charging, though it has wear time transmission limits. Contraindicated for critical care patients. Designed for patient comfort and compliance while enabling continuous, uninterrupted cardiac monitoring.
MyZio Patient App
softwarePatient-facing mobile app for cardiac monitoring support and engagement
A mobile application that supports patients throughout their cardiac monitoring journey. Features include digital symptom logging, educational content about heart health and arrhythmias, medication reminders, and guidance for using Zio monitors. Designed to improve patient engagement and compliance during the monitoring period.
ZioSuite
platformComprehensive clinician portal for cardiac monitoring data management and reporting
A cloud-based clinical portal that allows healthcare providers to interpret reports, manage patients, and access cardiac monitoring data from computer or mobile devices. Includes a provider mobile app for on-the-go access. Integrates with EHR systems to simplify data collection and entry, enhance interdisciplinary access, and boost workflow efficiency.
iRhythm AI Algorithm
modelFDA-cleared deep learning algorithm for automated ECG analysis and arrhythmia detection
The first FDA-cleared, deep-learned AI algorithm for cardiac rhythm analysis, proven to be as accurate as expert cardiologists. Processes over 2 billion hours of curated heartbeat data from more than 12 million patients analyzed. The algorithm generates comprehensive reports verified by Qualified Cardiac Technicians (QCTs), achieving 99% physician agreement with end-of-wear reports.
Zio monitor
FlagshipdeviceAdvanced ECG patch monitor for continuous cardiac arrhythmia detection
A state-of-the-art, patient-friendly wearable ECG monitor designed for extended continuous cardiac monitoring. The device captures uninterrupted heart rhythm data with near-perfect patient compliance (99%), enabling high diagnostic yield for arrhythmia detection including atrial fibrillation. Features comfortable, easy-to-wear design that patients can use without battery changes or charging requirements.
iRhythm Cardiac Monitoring Service
FlagshipserviceEnd-to-end cardiac monitoring service combining devices, AI analysis, and clinical reporting
A comprehensive cardiac monitoring solution that integrates Zio ECG monitors, FDA-cleared AI-assisted analysis, expert clinical review by Qualified Cardiac Technicians, and physician-ready actionable reports. The service includes the ZioSuite portal, seamless EHR integration, patient support via MyZio app, and 24/7/365 billing and customer support. Delivers highest diagnostic yield and lowest likelihood of retesting compared to other ambulatory cardiac monitoring services.
Customer Success Stories
Commercially insured patient populations (AVALON Study)
payer
Assessment of variation in ambulatory cardiac monitoring strategies examining how monitoring approach influenced arrhythmia diagnosis, clinical outcomes, and healthcare resource utilization
Medicare beneficiaries study
government
Comparative effectiveness study of ambulatory cardiac monitoring strategies in Medicare population to assess diagnostic yield, clinical outcomes, and healthcare utilization
Over 12 million patients analyzed
other
Real-world deployment of iRhythm cardiac monitoring service across diverse patient populations for arrhythmia detection and diagnosis
Hiring Activity
View Open Roles →Product & Market
Product Stage
enterprisePrimary Market
providersCompany Details
- Founded
- 2006
- Headquarters
- San Francisco, CA, USA
- Employees
- 1001
- Stage
- public
- Profile last updated
- June 22, 2026
Official Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingData Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.